As filed with the Securities and Exchange Commission on November 6, 2019

 

Registration No. 333-

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM S-8

 

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 

Centogene B.V.*

(Exact Name of Registrant as specified in its charter)

 

The Netherlands

 

N/A

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

Am Strande 7
18055 Rostock, Germany
+49 (381) 80113400
(Address including zip code of Principal Executive Offices)

 

Centogene N.V. Long-Term Incentive Plan

(Full title of the plans)

 

Cogency Global Inc.
10 E 40th Street, 10th floor
New York, New York 10016
+1 (800) 221-0102

(Name, address and telephone number, including area code, of agent for service)

 

Copies to:
Leo Borchardt
Richard D. Truesdell, Jr.

Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

 

Accelerated filer o

Non-accelerated filer x

 

Smaller reporting company o

 

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  o

 

CALCULATION OF REGISTRATION FEE

 

Title of Securities to be Registered

 

Amount to
be
Registered
(1)

 

Proposed
Maximum
Offering Price
Per Share

 

Proposed
Maximum
Aggregate
Offering Price

 

Amount of
Registration
Fee (4)

Common Shares, par value €0.12 each, reserved for issuance pursuant to the Centogene N.V. Long-Term Incentive Plan

 

805,308

 

$

0.13

(2)

$

104,690.12

 

$

13.59

Common Shares, par value €0.12 each, available for future issuance pursuant to the Centogene N.V. Long-Term Incentive Plan

 

2,581,975

 

$

14.00

(3)

$

36,147,650.00

 

$

4,691.96

 

 

(1)                                 This Registration Statement on Form S-8 (this “Registration Statement”) covers common shares, each with a nominal value of €0.12 per share (“Common Shares”), of Centogene N.V., after giving effect to the conversion of Centogene B.V. into Centogene N.V. (the “Registrant”) issuable pursuant to the plans set forth in this table (collectively, the “Plans”). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional Common Shares that become issuable under the Plans by reason of any share dividend, share split, recapitalization or other similar transaction.

 

(2)                                 Estimated pursuant to Rule 457(c) and 457(h) under the Securities Act, solely for the purpose of computing the registration fee, based on an exchange rate on November 1, 2019 of approximately $1.00 to €1.2950

 

(3)                                 Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act on the basis of the price per share of the Registrant’s proposed initial public offering.

 

(4)                                 Rounded up to the nearest penny in U.S. dollars.

 

(*) We intend to convert the legal form of our company under Dutch law from a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) to a public company (naamloze vennootschap) and to change our name from Centogene B.V. to Centogene N.V. prior to the closing of our offering on Registration No. 333-234177.

 

 

 


 

PART I

 

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

The documents containing the information specified in Item 1 and Item 2 of Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

The following documents are incorporated herein by reference:

 

(a)                                 The Registrant’s Registration Statement on Form F-1, Amendment No. 1, filed with the Commission on October 28, 2019 (Registration No. 333-234177).

 

(b)                                 All reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of the Registrant’s Registration Statement referred to in clause (a) above.

 

(c)                                  The description of the Registrant’s share capital which is contained in the Registrant’s Registration Statement Form 8-A filed with the Commission on November 4, 2019 (Registration No. 001-39124), including any amendments or supplements thereto.

 

In addition, all documents subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, including any Reports of Foreign Private Issuers on Form 6-K submitted during such period (or portion thereof) that is identified in such form as being incorporated by reference into this Registration Statement, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents. The Registrant is not incorporating by reference any documents or portions thereof, whether specifically listed above or filed in the future, that are not deemed “filed” with the Commission.

 

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein), modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

Item 4. Description of Securities.

 

Not applicable.

 

Item 5. Interests of Named Experts and Counsel.

 

Not applicable.

 

Item 6. Indemnification of Directors and Officers.

 

Subject to certain exceptions, the Registrant’s articles of association (upon the Registrant’s conversion into Centogene N.V.) will provide for indemnification of its current and former managing directors and supervisory directors (and other current and former officers and employees as designated by the Registrant’s management board). No indemnification shall be given to an indemnified person:

 


 

(a)                                 if a competent court or arbitral tribunal has established, without having (or no longer having) the possibility for appeal, that the acts or omissions of such indemnified person that led to the financial losses, damages, expenses, suit, claim, action or legal proceedings as described above are of an unlawful nature (including acts or omissions which are considered to constitute malice, gross negligence, intentional recklessness and/or serious culpability attributable to such indemnified person);

 

(b)                                 to the extent that his or her financial losses, damages and expenses are covered under insurance and the relevant insurer has settled, or has provided reimbursement for, these financial losses, damages and expenses (or has irrevocably undertaken to do so);

 

(c)                                  in relation to proceedings brought by such indemnified person against the Registrant, except for proceedings brought to enforce indemnification to which he is entitled pursuant to the Registrant’s articles of association, pursuant to an agreement between such indemnified person and the Registrant which has been approved by the Registrant’s management board or pursuant to insurance taken out by the Registrant for the benefit of such indemnified person; and

 

(d)                                 for any financial losses, damages or expenses incurred in connection with a settlement of any proceedings effected without the Registrant’s prior consent.

 

Under the Registrant’s articles of association, its management board may stipulate additional terms, conditions and restrictions in relation to the indemnification described above. In addition, the Registrant has entered into indemnification agreements with all members of its management board and supervisory board.

 

Insofar as indemnification of liabilities arising under the Securities Act may be permitted to managing directors, supervisory directors or persons controlling the Registrant pursuant to the foregoing provisions, the Registrant has been informed that, in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

Item 7. Exemption from Registration Claimed.

 

Not applicable.

 

Item 8. Exhibits.

 

Exhibit
Number

 

 

 

 

 

4.1

 

Centogene N.V. Articles of Association, dated November 6, 2019, as they will be in effect immediately following the completion of the corporate reorganization (filed herewith)

 

 

 

4.2

 

Form of Registration Right Agreement (incorporated herein by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form F-1, filed on October 11, 2019 (Registration No. 333-234177))

 

 

 

5.1

 

Opinion of NautaDutilh N.V., Dutch counsel of the Registrant, as to the validity of the common shares (filed herewith)

 

 

 

23.1

 

Consent of NautaDutilh N.V., Dutch counsel of the Registrant (included in Exhibit 5.1)

 

 

 

23.2

 

Consent of Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft (filed herewith)

 

 

 

24.1

 

Powers of Attorney (included in the signature pages hereto)

 

 

 

99.1

 

Centogene N.V. Long-Term Incentive Plan, as it will be in effect immediately following the completion of the corporate reorganization (filed herewith)

 


 

Item 9. Undertakings.

 

(a)   The undersigned Registrant hereby undertakes:

 

(1)         To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

 

(i)                                     To include any prospectus required by Section 10(a)(3) of the Securities Act;

 

(ii)                                  To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement;

 

(iii)                               To include any material information with respect to the Plans not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

 

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

 

(2)         That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3)         To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(b)   The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(c)   Insofar as indemnification of liabilities arising under the Securities Act may be permitted to directors or persons controlling the Registrant pursuant to the foregoing provisions, the Registrant has been informed that, in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing this Registration Statement and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Berlin on this 6th day of November, 2019.

 

 

 

Centogene B.V.

 

 

 

 

 

By:

/s/ Arndt Rolfs

 

 

Name:

Arndt Rolfs

 

 

Title:

Chief Executive Officer

 

 

 

 

 

By:

/s/ Richard Stoffelen

 

 

Name:

Richard Stoffelen

 

 

Title:

Chief Financial Officer

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Arndt Rolfs and Richard Stoffelen as his or her true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and any and all additional registration statements pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorneys-in-fact and agent full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitutes may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Arndt Rolfs

 

Chief Executive Officer and Director

 

November 6, 2019

Arndt Rolfs

 

(principal executive officer)

 

 

 

 

 

 

 

/s/ Richard Stoffelen

 

Chief Financial Officer

 

November 6, 2019

Richard Stoffelen

 

(principal financial officer and principal
accounting officer)

 

 

 

 

 

 

 

/s/ Arndt Rolfs

 

Member of the Management Board

 

November 6, 2019

Arndt Rolfs

 

 

 

 

 

 

 

 

 

/s/ Richard Stoffelen

 

Member of the Management Board

 

November 6, 2019

Richard Stoffelen

 

 

 

 

 

 

 

 

 

/s/ Richard Arthur

 

Assistant Secretary on behalf of Cogency Global Inc. (Authorized Representative in the United States)

 

November 6, 2019

Richard Arthur

 

 

 

 


Exhibit 4.1

 

 

This is a translation into English of the official Dutch version of the articles of association of a public company with limited liability under Dutch law. In the event of a conflict between the English and Dutch texts, the Dutch text shall prevail.

 

ARTICLES OF ASSOCIATION

 

CENTOGENE N.V.

Dated November 6, 2019

 

 

DEFINITIONS AND INTERPRETATION

 

Article 1

 

1.1                              In these articles of association the following definitions shall apply:

 

Article

 

An article of these articles of association.

 

 

 

CEO

 

The Company’s chief executive officer.

 

 

 

Chairman

 

The chairman of the Supervisory Board.

 

 

 

Company

 

The company to which these articles of association pertain.

 

 

 

DCC

 

The Dutch Civil Code.

 

 

 

Dutch Corporate Governance Code

 

The code of conduct designated from time to time pursuant to Section 2:391(5) DCC.

 

 

 

General Meeting

 

The Company’s general meeting.

 

 

 

Group Company

 

An entity or partnership which is organisationally connected with the Company in an economic unit within the meaning of Section 2:24b DCC.

 

 

 

Indemnified Officer

 

A current or former Managing Director or Supervisory Director and such other current or former officer or employee of the Company or its Group Companies as designated by the Management Board.

 

 

 

Management Board

 

The Company’s management board.

 

 

 

Management Board Rules

 

The internal rules applicable to the Management Board, as drawn up by the Management Board.

 

 

 

Managing Director

 

A member of the Management Board.

 

 

 

Meeting Rights

 

With respect to the Company, the rights attributed by law to the holders of depository receipts issued for shares with a company’s cooperation, including the right to attend and address a General Meeting.

 

1


 

Person with Meeting Rights

 

A shareholder, a usufructuary or pledgee with voting rights or a holder of depository receipts for shares issued with the Company’s cooperation.

 

 

 

Record Date

 

The date of registration for a General Meeting as provided by law.

 

 

 

Simple Majority

 

More than half of the votes cast.

 

 

 

Subsidiary

 

A subsidiary of the Company within the meaning of Section 2:24a DCC.

 

 

 

Supervisory Board

 

The Company’s supervisory board.

 

 

 

Supervisory Board Rules

 

The internal rules applicable to the Supervisory Board, as drawn up by the Supervisory Board.

 

 

 

Supervisory Director

 

A member of the Supervisory Board.

 

1.2                              Unless the context requires otherwise, references to “shares” or “shareholders” are to shares in the Company’s capital or to the holders thereof, respectively.

 

1.3                              References to statutory provisions are to those provisions as they are in force from time to time.

 

1.4                              Terms that are defined in the singular have a corresponding meaning in the plural.

 

1.5                              Words denoting a gender include each other gender.

 

1.6                              Except as otherwise required by law, the terms “written” and “in writing” include the use of electronic means of communication.

 

NAME AND SEAT

 

Article 2

 

2.1                              The Company’s name is Centogene N.V.

 

2.2                              The Company has its corporate seat in Amsterdam.

 

OBJECTS

 

Article 3

 

The Company’s objects are:

 

a.                                     to develop, license, manufacture and commercialize diagnostic and pharmaceutical products

 

2


 

and services;

 

b.                                     to develop and commercialise diagnostic and pharmaceutical tests and analytical methods;

 

c.                                      to incorporate, to participate in, to finance, to hold any other interest in and to conduct the management or supervision of other entities, companies, partnerships and businesses;

 

d.                                     to acquire, to manage, to invest, to exploit, to encumber and to dispose of assets and liabilities;

 

e.                                      to furnish guarantees, to provide security, to warrant performance in any other way and to assume liability, whether jointly and severally or otherwise, in respect of obligations of Group Companies or other parties; and

 

f.                                       to do anything which, in the widest sense, is connected with or may be conducive to the objects described above.

 

SHARES - AUTHORISED SHARE CAPITAL AND DEPOSITORY RECEIPTS

 

Article 4

 

4.1                              The Company’s authorised share capital amounts to nine million four hundred and eighty thousand euro (EUR 9,480,000).

 

4.2                              The authorised share capital is divided into seventy-nine million (79,000,000) shares, each having a nominal value of twelve eurocents (EUR 0.12).

 

4.3                              The Management Board may resolve that one or more shares are divided into such number of fractional shares as may be determined by the Management Board. Unless specified differently, the provisions of these articles of association concerning shares and shareholders apply mutatis mutandis to fractional shares and the holders thereof, respectively.

 

4.4                              The Company may cooperate with the issue of depository receipts for shares in its capital.

 

SHARES - FORM OF SHARES AND SHARE REGISTER

 

Article 5

 

5.1                              All shares are registered shares. The Company may issue share certificates for registered shares in such form as may be approved by the Management Board. Each Managing Director is authorised to sign any such share certificate on behalf of the Company.

 

5.2                              Shares shall be numbered consecutively, starting from 1.

 

5.3                              The Management Board shall keep a register setting out the names and addresses of all

 

3


 

shareholders and all holders of a usufruct or pledge in respect of shares. The register shall also set out any other particulars that must be included in the register pursuant to applicable law. Part of the register may be kept outside the Netherlands to comply with applicable local law or pursuant to stock exchange rules.

 

5.4                              Shareholders, usufructuaries and pledgees shall provide the Management Board with the necessary particulars in a timely fashion. Any consequences of not, or incorrectly, notifying such particulars shall be borne by the party concerned.

 

5.5                              All notifications may be sent to shareholders, usufructuaries and pledgees at their respective addresses as set out in the register.

 

SHARES - ISSUE

 

Article 6

 

6.1                              Shares can be issued pursuant to a resolution of the General Meeting or of another body authorised by the General Meeting for this purpose for a specified period not exceeding five years. When granting such authorisation, the number of shares that may be issued must be specified. The authorisation may be extended, in each case for a period not exceeding five years. Unless stipulated differently when granting the authorisation, the authorisation cannot be revoked. For as long as and to the extent that another body has been authorised to resolve to issue shares, the General Meeting shall not have this authority.

 

6.2                              Article 6.1 applies mutatis mutandis to the granting of rights to subscribe for shares, but does not apply in respect of issuing shares to a party exercising a previously acquired right to subscribe for shares.

 

6.3                              The Company may not subscribe for shares in its own capital.

 

SHARES - PRE-EMPTION RIGHTS

 

Article 7

 

7.1                              Upon an issue of shares, each shareholder shall have a pre-emption right in proportion to the aggregate nominal value of his shares.

 

7.2                              In deviation of Article 7.1, shareholders do not have pre-emption rights in respect of:

 

a.                                     shares issued against non-cash contribution; or

 

b.                                     shares issued to employees of the Company or of a Group Company.

 

7.3                              The Company shall announce an issue with pre-emption rights and the period during which those rights can be exercised in the Dutch State Gazette and in a daily newspaper

 

4


 

with national distribution, unless the announcement is sent in writing to all shareholders at the addresses submitted by them.

 

7.4                              Pre-emption rights may be exercised for a period of at least two weeks after the date of announcement in the State Gazette or after the announcement was sent to the shareholders.

 

7.5                              Pre-emption rights may be limited or excluded by a resolution of the General Meeting or of the body authorised as referred to in Article 6.1, if that body was authorised by the General Meeting for this purpose for a specified period not exceeding five years. The authorisation may be extended, in each case for a period not exceeding five years. Unless stipulated differently when granting the authorisation, the authorisation cannot be revoked. For as long as and to the extent that another body has been authorised to resolve to limit or exclude pre-emption rights, the General Meeting shall not have this authority.

 

7.6                              A resolution of the General Meeting to limit or exclude pre-emption rights, or to grant an authorisation as referred to in Article 7.5, shall require a majority of at least two thirds of the votes cast if less than half of the issued share capital is represented at the General Meeting.

 

7.7                              The preceding provisions of this Article 7 apply mutatis mutandis to the granting of rights to subscribe for shares, but do not apply in respect of issuing shares to a party exercising a previously acquired right to subscribe for shares.

 

SHARES - PAYMENT

 

Article 8

 

8.1                              Without prejudice to Section 2:80(2) DCC, the nominal value of a share and, if the share is subscribed for at a higher price, the difference between these amounts must be paid up upon subscription for that share.

 

8.2                              Shares must be paid up in cash, except to the extent that payment by means of a contribution in another form has been agreed.

 

8.3                              Payment in a currency other than the euro may only be made with the Company’s consent. Where such a payment is made, the payment obligation is satisfied for the amount in euro for which the paid amount can be freely exchanged. Without prejudice to the last sentence of Section 2:80a(3) DCC, the date of the payment determines the exchange rate.

 

5


 

SHARES - FINANCIAL ASSISTANCE

 

Article 9

 

9.1                              The Company may not provide security, give a price guarantee, warrant performance in any other way or commit itself jointly and severally or otherwise with or for others with a view to the subscription for or acquisition of shares or depository receipts for shares in its capital by others. This prohibition applies equally to Subsidiaries.

 

9.2                              The Company and its Subsidiaries may not provide loans with a view to the subscription for or acquisition of shares or depository receipts for shares in the Company’s capital by others, unless the Management Board resolves to do so and Section 2:98c DCC is observed.

 

9.3                              The preceding provisions of this Article 9 do not apply if shares or depository receipts for shares are subscribed for or acquired by or for employees of the Company or of a Group Company.

 

SHARES - ACQUISITION OF OWN SHARES

 

Article 10

 

10.1                       The acquisition by the Company of shares in its own capital which have not been fully paid up shall be null and void.

 

10.2                       The Company may only acquire fully paid up shares in its own capital for no consideration or if and to the extent that the General Meeting has authorised the Management Board for this purpose and all other relevant statutory requirements of Section 2:98 DCC are observed.

 

10.3                       An authorisation as referred to in Article 10.2 remains valid for no longer than eighteen months. When granting such authorisation, the General Meeting shall determine the number of shares that may be acquired, how they may be acquired and within which range the acquisition price must be. An authorisation shall not be required for the Company to acquire shares in its own capital in order to transfer them to employees of the Company or of a Group Company pursuant to an arrangement applicable to them, provided that these shares are included on the price list of a stock exchange.

 

10.4                       Without prejudice to Articles 10.1 through 10.3, the Company may acquire shares in its own capital for cash consideration or for consideration satisfied in the form of assets. In the case of a consideration being satisfied in the form of assets, the value thereof, as determined by the Management Board, must be within the range stipulated by the General Meeting as referred to in Article 10.3.

 

10.5                       The previous provisions of this Article 10 do not apply to shares acquired by the Company

 

6


 

under universal title of succession.

 

10.6                       In this Article 10, references to shares include depository receipts for shares.

 

SHARES - REDUCTION OF ISSUED SHARE CAPITAL

 

Article 11

 

11.1                       The General Meeting can resolve to reduce the Company’s issued share capital by cancelling shares or by reducing the nominal value of shares by virtue of an amendment to these articles of association. The resolution must designate the shares to which the resolution relates and it must provide for the implementation of the resolution.

 

11.2                       A resolution to cancel shares may only relate to shares held by the Company itself or in respect of which the Company holds the depository receipts.

 

11.3                       A resolution of the General Meeting to reduce the Company’s issued share capital shall require a majority of at least two thirds of the votes cast if less than half of the issued share capital is represented at the General Meeting.

 

SHARES - ISSUE AND TRANSFER REQUIREMENTS

 

Article 12

 

12.1                       Except as otherwise provided or allowed by Dutch law, the issue or transfer of a share shall require a deed to that effect and, in the case of a transfer and unless the Company itself is a party to the transaction, acknowledgement of the transfer by the Company.

 

12.2                       The acknowledgement shall be set out in the deed or shall be made in such other manner as prescribed by law.

 

12.3                       For as long as any shares are admitted to trading on the New York Stock Exchange, the NASDAQ Stock Market or on any other regulated stock exchange operating in the United States of America, the laws of the State of New York shall apply to the property law aspects of the shares reflected in the register administered by the relevant transfer agent, without prejudice to Sections 10:140 and 10:141 DCC.

 

7


 

SHARES - USUFRUCT AND PLEDGE

 

Article 13

 

13.1                       Shares can be encumbered with a usufruct or pledge.

 

13.2                       The voting rights attached to a share which is subject to a usufruct or pledge vest in the shareholder concerned.

 

13.3                       In deviation of Article 13.2, the holder of a usufruct or pledge on shares shall have the voting rights attached thereto if this was provided for when the usufruct or pledge was created.

 

13.4                       Usufructuaries and pledgees without voting rights shall not have Meeting Rights.

 

MANAGEMENT BOARD - COMPOSITION

 

Article 14

 

14.1        The Company has a Management Board consisting of one or more Managing Directors. The Management Board shall be composed of individuals.

 

14.2        The Supervisory Board shall determine the number of Managing Directors.

 

14.3                       The Supervisory Board shall elect a Managing Director to be the CEO. The Supervisory Board may dismiss the CEO, provided that the Managing Director so dismissed shall subsequently continue his term of office as a Managing Director without having the title of CEO.

 

14.4                       If a Managing Director is absent or incapacitated, he may be replaced temporarily by a person whom the Management Board has designated for that purpose and, until then, the other Managing Director(s) shall be charged with the management of the Company. If all Managing Directors are absent or incapacitated, the management of the Company shall be attributed to the Supervisory Board. The person(s) charged with the management of the Company in this manner, may designate one or more persons to be charged with the management of the Company instead of, or together with, such person(s).

 

14.5                       A Managing Director shall be considered to be unable to act within the meaning of Article 14.4:

 

a.                                     during the existence of a vacancy on the Management Board, including as a result of:

 

i.                                        his death;

 

ii.                                    his dismissal by the General Meeting, other than at the proposal of the

 

8


 

Supervisory Board; or

 

iii.                                his voluntary resignation before his term of office has expired;

 

iv.                                 not being reappointed by the General Meeting, notwithstanding a (binding) nomination to that effect by the Supervisory Board,

 

provided that the Supervisory Board may always decide to decrease the number of Managing Directors such that a vacancy no longer exists; or

 

b.                                     during his suspension; or

 

c.                                      in a period during which the Company has not been able to contact him (including as a result of illness), provided that such period lasted longer than five consecutive days (or such other period as determined by the Supervisory Board on the basis of the facts and circumstances at hand).

 

MANAGEMENT BOARD - APPOINTMENT, SUSPENSION AND DISMISSAL

 

Article 15

 

15.1                       The General Meeting shall appoint the Managing Directors and may at any time suspend or dismiss any Managing Director. In addition, the Supervisory Board may at any time suspend a Managing Director. A suspension by the Supervisory Board can at any time be lifted by the General Meeting.

 

15.2                       The General Meeting can only appoint Managing Directors upon a nomination by the Supervisory Board. The General Meeting may at any time resolve to render such nomination to be non-binding by a majority of at least two thirds of the votes cast representing more than half of the issued share capital. If a nomination is rendered non-binding, a new nomination shall be made by the Supervisory Board. If the nomination comprises one candidate for a vacancy, a resolution concerning the nomination shall result in the appointment of the candidate, unless the nomination is rendered non-binding. A second meeting as referred to in Section 2:120(3) DCC cannot be convened.

 

15.3                       At a General Meeting, a resolution to appoint a Managing Director can only be passed in respect of candidates whose names are stated for that purpose in the agenda of that General Meeting or the explanatory notes thereto.

 

9


 

15.4                       A resolution of the General Meeting to suspend or dismiss a Managing Director shall require a majority of at least two thirds of the votes cast representing more than half of the issued share capital, unless the resolution is passed at the proposal of the Supervisory Board. A second meeting as referred to in Section 2:120(3) DCC cannot be convened.

 

15.5                       If a Managing Director is suspended and the General Meeting does not resolve to dismiss him within three months from the date of such suspension, the suspension shall lapse.

 

MANAGEMENT BOARD - DUTIES AND ORGANISATION

 

Article 16

 

16.1                       The Management Board is charged with the management of the Company, subject to the restrictions contained in these articles of association. In performing their duties, Managing Directors shall be guided by the interests of the Company and of the business connected with it.

 

16.2                       The Management Board shall draw up Management Board Rules concerning its organisation, decision-making and other internal matters, with due observance of these articles of association. In performing their duties, the Managing Directors shall act in compliance with the Management Board Rules.

 

16.3                       The Management Board may perform the legal acts referred to in Section 2:94(1) DCC without the prior approval of the General Meeting.

 

MANAGEMENT BOARD - DECISION-MAKING

 

Article 17

 

17.1                       Without prejudice to Article 17.5, each Managing Director may cast one vote in the decision-making of the Management Board.

 

17.2                       A Managing Director can be represented by another Managing Director holding a written proxy for the purpose of the deliberations and the decision-making of the Management Board.

 

17.3                       Resolutions of the Management Board shall be passed, irrespective of whether this occurs at a meeting or otherwise, by Simple Majority unless the Management Board Rules provide

 

10


 

differently.

 

17.4                       Invalid votes, blank votes and abstentions shall not be counted as votes cast. Managing Directors who casted an invalid or blank vote or who abstained from voting shall be taken into account when determining the number of Managing Directors who are present or represented at a meeting of the Management Board.

 

17.5                       Where there is a tie in any vote of the Management Board, the CEO shall have a casting vote, provided that the CEO cannot cast more votes than the other Managing Directors together. Otherwise, the relevant resolution shall not have been passed.

 

17.6                       A Managing Director shall not participate in the deliberations and decision-making of the Management Board on a matter in relation to which he has a direct or indirect personal interest which conflicts with the interests of the Company and of the business connected with it. If, as a result thereof, no resolution can be passed by the Management Board, the resolution shall be passed by the Supervisory Board.

 

17.7                       Meetings of the Management Board can be held through audio-communication facilities, unless a Managing Director objects thereto.

 

17.8                       Resolutions of the Management Board may, instead of at a meeting, be passed in writing, provided that all Managing Directors are familiar with the resolution to be passed and none of them objects to this decision-making process. Articles 17.1 through 17.6 apply mutatis mutandis.

 

17.9                       The approval of the Supervisory Board is required for resolutions of the Management Board concerning the following matters:

 

a.                                     the making of a proposal to the General Meeting concerning:

 

i.                                        the issue of shares or the granting of rights to subscribe for shares;

 

ii.                                    the limitation or exclusion of pre-emption rights;

 

iii.                                the designation or granting of an authorisation as referred to in Articles 6.1, 7.5 and 10.2, respectively;

 

iv.                                 the reduction of the Company’s issued share capital;

 

v.                                     the making of a distribution from the Company’s profits or reserves;

 

vi.                                 the determination that all or part of a distribution, instead of being made in cash, shall be made in the form of shares in the Company’s capital or in the form of assets;

 

vii.                             the amendment of these articles of association;

 

viii.                         the entering into of a merger or demerger;

 

ix.                                 the instruction of the Management Board to apply for the Company’s

 

11


 

bankruptcy; and

 

x.                                     the Company’s dissolution;

 

b.                                     the issue of shares or the granting of rights to subscribe for shares;

 

c.                                      the limitation or exclusion of pre-emption rights;

 

d.                                     the acquisition of shares by the Company in its own capital, including the determination of the value of a non-cash consideration for such an acquisition as referred to in Article 10.4;

 

e.                                      the drawing up or amendment of the Management Board Rules;

 

f.                                       the performance of the legal acts described in Article 16.3 and 17.10;

 

g.                                     the charging of amounts to be paid up on shares against the Company’s reserves as described in Article 34.4;

 

h.                                     the making of an interim distribution; and

 

i.                                        such other resolutions of the Management Board as the Supervisory Board shall have specified in a resolution to that effect and notified to the Management Board.

 

17.10                The approval of the General Meeting is required for resolutions of the Management Board concerning a material change to the identity or the character of the Company or the business, including in any event:

 

a.                                     transferring the business or materially all of the business to a third party;

 

b.                                     entering into or terminating a long-lasting alliance of the Company or of a Subsidiary either with another entity or company, or as a fully liable partner of a limited partnership or general partnership, if this alliance or termination is of significant importance for the Company; and

 

c.                                      acquiring or disposing of an interest in the capital of a company by the Company or by a Subsidiary with a value of at least one third of the value of the assets, according to the balance sheet with explanatory notes or, if the Company prepares a consolidated balance sheet, according to the consolidated balance sheet with explanatory notes in the Company’s most recently adopted annual accounts.

 

17.11                The absence of the approval of the Supervisory Board or the General Meeting of a resolution as referred to in Articles 17.9 or 17.10, respectively, shall result in the relevant resolution being null and void pursuant to Section 2:14(1) DCC but shall not affect the powers of representation of the Management Board or of the Managing Directors.

 

12


 

MANAGEMENT BOARD - COMPENSATION

 

Article 18

 

18.1                       The General Meeting shall determine the Company’s policy concerning the compensation of the Management Board with due observance of the relevant statutory requirements.

 

18.2                       The compensation of Managing Directors shall be determined by the Supervisory Board with due observance of the policy referred to in Article 18.1.

 

18.3                       The Supervisory Board shall submit proposals concerning compensation arrangements for the Management Board in the form of shares or rights to subscribe for shares to the General Meeting for approval. This proposal must at least include the number of shares or rights to subscribe for shares that may be awarded to the Management Board and which criteria apply for such awards or changes thereto. The absence of the approval of the General Meeting shall not affect the powers of representation.

 

MANAGEMENT BOARD - REPRESENTATION

 

Article 19

 

19.1                       The Management Board is entitled to represent the Company.

 

19.2                       The power to represent the Company also vests in the CEO individually, as well as in any other two Managing Directors acting jointly.

 

19.3                       The Company may also be represented by the holder of a power of attorney to that effect. If the Company grants a power of attorney to an individual, the Management Board may grant an appropriate title to such person.

 

SUPERVISORY BOARD - COMPOSITION

 

Article 20

 

20.1                       The Company has a Supervisory Board consisting of one or more Supervisory Directors. The Supervisory Board shall be composed of individuals.

 

20.2                        The Supervisory Board shall determine the number of Supervisory Directors.

 

20.3                       The Supervisory Board shall elect a Supervisory Director to be the Chairman. The Supervisory Board may dismiss the Chairman, provided that the Supervisory Director so dismissed shall subsequently continue his term of office as a Supervisory Director without having the title of Chairman.

 

20.4                       Where a Supervisory Director is no longer in office or is unable to act, he may be replaced temporarily by a person whom the Supervisory Board has designated for that purpose and, until then, the other Supervisory Director(s) shall be charged with the supervision of the Company. Where all Supervisory Directors are no longer in office or are unable to act, the supervision of the Company shall be attributed to the former Supervisory Director who

 

13


 

most recently ceased to hold office as the Chairman, provided that he is willing and able to accept that position, who may designate one or more other persons to be charged with the supervision of the Company (instead of, or together with, such former Supervisory Director). The person(s) charged with the supervision of the Company pursuant to the previous sentence shall cease to hold that position when the General Meeting has appointed one or more persons as Supervisory Director(s). Article 14.5 applies mutatis mutandis.

 

SUPERVISORY BOARD - APPOINTMENT, SUSPENSION AND DISMISSAL

 

Article 21

 

21.1                       The General Meeting shall appoint the Supervisory Directors and may at any time suspend or dismiss any Supervisory Director.

 

21.2                       The General Meeting can only appoint a Supervisory Director upon a nomination by the Supervisory Board. The General Meeting may at any time resolve to render such nomination to be non-binding by a majority of at least two thirds of the votes cast representing more than half of the issued share capital. If a nomination is rendered non-binding, a new nomination shall be made by the Supervisory Board. A second meeting as referred to in Section 2:120(3) DCC cannot be convened.

 

21.3                       Upon the making of a nomination for the appointment of a Supervisory Director, the following information shall be provided with respect to the candidate:

 

a.                                     his age and profession;

 

b.                                     the aggregate nominal value of the shares held by him in the Company’s capital;

 

c.                                      his present and past positions, to the extent that these are relevant for the performance of the tasks of a Supervisory Director;

 

d.                                     the names of any entities of which he is already a supervisory director or a non-executive director; if these include entities that form part of the same group, a specification of the group’s name shall suffice.

 

The nomination must be supported by reasons. In the case of a reappointment, the manner in which the candidate has fulfilled his duties as a Supervisory Director shall be taken into account.

 

21.4                       At a General Meeting, a resolution to appoint a Supervisory Director can only be passed in respect of candidates whose names are stated for that purpose in the agenda of that General Meeting or in the explanatory notes thereto.

 

14


 

21.5                       A resolution of the General Meeting to suspend or dismiss a Supervisory Director shall require a majority of at least two thirds of the votes cast representing more than half of the issued share capital, unless the resolution is passed at the proposal of the Supervisory Board. A second meeting as referred to in Section 2:120(3) DCC cannot be convened.

 

21.6                       If a Supervisory Director is suspended and the General Meeting does not resolve to dismiss him within three months from the date of such suspension, the suspension shall lapse.

 

SUPERVISORY BOARD - DUTIES AND ORGANISATION

 

Article 22

 

22.1                       The Supervisory Board is charged with the supervision of the policy of the Management Board and the general course of affairs of the Company and of the business connected with it. The Supervisory Board shall provide the Management Board with advice. In performing their duties, Supervisory Directors shall be guided by the interests of the Company and of the business connected with it.

 

22.2                       The Management Board shall provide the Supervisory Board with the information necessary for the performance of its tasks in a timely fashion. At least once a year, the Management Board shall inform the Supervisory Board in writing of the main features of the strategic policy, the general and financial risks and the administration and control system of the Company.

 

22.3                       The Supervisory Board shall draw up Supervisory Board Rules concerning its organisation, decision-making and other internal matters, with due observance of these articles of association. In performing their duties, the Supervisory Directors shall act in compliance with the Supervisory Board Rules.

 

22.4                       The Supervisory Board shall establish the committees which the Company is required to have and otherwise such committees as are deemed to be appropriate by the Supervisory Board. The Supervisory Board shall draw up (and/or include in the Supervisory Board Rules) rules concerning the organisation, decision-making and other internal matters of its committees.

 

SUPERVISORY BOARD - DECISION-MAKING

 

Article 23

 

23.1                       Without prejudice to Article 23.5, each Supervisory Director may cast one vote in the decision-making of the Supervisory Board.

 

15


 

23.2                       A Supervisory Director can be represented by another Supervisory Director holding a written proxy for the purpose of the deliberations and the decision-making of the Supervisory Board.

 

23.3                       Resolutions of the Supervisory Board shall be passed, irrespective of whether this occurs at a meeting or otherwise, by Simple Majority unless the Supervisory Board Rules provide differently.

 

23.4                       Invalid votes, blank votes and abstentions shall not be counted as votes cast. Supervisory Directors who casted an invalid or blank vote or who abstained from voting shall be taken into account when determining the number of Supervisory Directors who are present or represented at a meeting of the Supervisory Board.

 

23.5                       Where there is a tie in any vote of the Supervisory Board, the Chairman shall have a casting vote, provided that the Chairman cannot cast more votes than the other Supervisory Directors together. Otherwise, the relevant resolution shall not have been passed.

 

23.6                       A Supervisory Director shall not participate in the deliberations and decision-making of the Supervisory Board on a matter in relation to which he has a direct or indirect personal interest which conflicts with the interests of the Company and of the business connected with it. If, as a result thereof, no resolution can be passed by the Supervisory Board, the resolution may nevertheless be passed by the Supervisory Board as if none of the Supervisory Directors has a conflict of interests as described in the previous sentence.

 

23.7                       Meetings of the Supervisory Board can be held through audio-communication facilities, unless a Supervisory Director objects thereto.

 

23.8                       Resolutions of the Supervisory Board may, instead of at a meeting, be passed in writing, provided that all Supervisory Directors are familiar with the resolution to be passed and none of them objects to this decision-making process. Articles 23.1 through 23.6 apply mutatis mutandis.

 

SUPERVISORY BOARD - COMPENSATION

 

Article 24

 

The General Meeting may grant a compensation to the Supervisory Directors.

 

INDEMNITY

 

Article 25

 

25.1        The Company shall indemnify and hold harmless each of its Indemnified Officers against:

 

a.                                      any financial losses or damages incurred by such Indemnified Officer; and

 

16


 

b.                                      any expense reasonably paid or incurred by such Indemnified Officer in connection with any threatened, pending or completed suit, claim, action or legal proceedings of a civil, criminal, administrative or other nature, formal or informal, in which he becomes involved,

 

to the extent this relates to his current or former position with the Company and/or a Group Company and in each case to the extent permitted by applicable law.

 

25.2                        No indemnification shall be given to an Indemnified Officer:

 

a.                                      if a competent court or arbitral tribunal has established, without having (or no longer having) the possibility for appeal, that the acts or omissions of such Indemnified Officer that led to the financial losses, damages, expenses, suit, claim, action or legal proceedings as described in Article 25.1 are of an unlawful nature (including acts or omissions which are considered to constitute malice, gross negligence, intentional recklessness and/or serious culpability attributable to such Indemnified Officer);

 

b.                                      to the extent that his financial losses, damages and expenses are covered under insurance and the relevant insurer has settled, or has provided reimbursement for, these financial losses, damages and expenses (or has irrevocably undertaken to do so);

 

c.                                       in relation to proceedings brought by such Indemnified Officer against the Company, except for proceedings brought to enforce indemnification to which he is entitled pursuant to these articles of association, pursuant to an agreement between such Indemnified Officer and the Company which has been approved by the Management Board or pursuant to insurance taken out by the Company for the benefit of such Indemnified Officer;

 

d.                                      for any financial losses, damages or expenses incurred in connection with a settlement of any proceedings effected without the Company’s prior consent.

 

25.3                        The Management Board may stipulate additional terms, conditions and restrictions in relation to the indemnification referred to in Article 25.1.

 

GENERAL MEETING - CONVENING AND HOLDING MEETINGS

 

Article 26

 

26.1                       Annually, at least one General Meeting shall be held. This annual General Meeting shall be held within six months after the end of the Company’s financial year.

 

26.2                       A General Meeting shall also be held:

 

a.                                     within three months after the Management Board has considered it to be likely that the Company’s equity has decreased to an amount equal to or lower than half of its paid up and called up capital, in order to discuss the measures to be taken if

 

17


 

so required; and

 

b.                                     whenever the Management Board or the Supervisory Board so decides.

 

26.3                       General Meetings must be held in the place where the Company has its corporate seat or in Arnhem, Assen, The Hague, Haarlem, ‘s-Hertogenbosch, Groningen, Leeuwarden, Lelystad, Maastricht, Middelburg, Rotterdam, Schiphol (Haarlemmermeer), Utrecht or Zwolle.

 

26.4                       If the Management Board and the Supervisory Board have failed to ensure that a General Meeting as referred to in Articles 26.1 or 26.2 paragraph a. is held, each Person with Meeting Rights may be authorised by the court in preliminary relief proceedings to do so.

 

26.5                       One or more Persons with Meeting Rights who collectively represent at least the part of the Company’s issued share capital prescribed by law for this purpose may request the Management Board and the Supervisory Board in writing to convene a General Meeting, setting out in detail the matters to be discussed. If neither the Management Board nor the Supervisory Board (each in that case being equally authorised for this purpose) has taken the steps necessary to ensure that the General Meeting could be held within the relevant statutory period after the request, the requesting Person(s) with Meeting Rights may be authorised, at his/their request, by the court in preliminary relief proceedings to convene a General Meeting.

 

26.6                       Any matter of which the discussion has been requested in writing by one or more Persons with Meeting Rights who, individually or collectively, represent at least the part of the Company’s issued share capital prescribed by law for this purpose shall be included in the convening notice or announced in the same manner, if the Company has received the substantiated request or a proposal for a resolution no later than on the sixtieth day prior to that of the General Meeting.

 

26.7                       Persons with Meeting Rights who wish to exercise their rights as described in Articles 26.5 and 26.6 should first consult the Management Board. If the intended exercise of such rights might result in a change to the Company’s strategy, including by dismissing one or more Managing Directors or Supervisory Directors, the Management Board shall be given the opportunity to invoke a reasonable period to respond to such intention. Such period shall not exceed the term stipulated by Dutch law and/or the Dutch Corporate Governance Code for that purpose. The Person(s) with Meeting Rights concerned should respect the response time stipulated by the Management Board. If invoked, the Management Board shall use such response period for further deliberation and constructive consultation, in any event with the Person(s) with Meeting Rights concerned, and shall explore the alternatives. At the end of the response time, the Management Board shall report on this consultation

 

18


 

and the exploration of alternatives to the General Meeting. This shall be supervised by the Supervisory Board. The response period may be invoked only once for any given General Meeting and shall not apply in the situations stipulated by Dutch law and/or the Dutch Corporate Governance Code for that purpose.

 

26.8                       A General Meeting must be convened with due observance of the relevant statutory minimum convening period.

 

26.9                       All Persons with Meeting Rights must be convened for the General Meeting in accordance with applicable law. The shareholders may be convened for the General Meeting by means of convening letters sent to the addresses of those shareholders in accordance with Article 5.5. The previous sentence does not prejudice the possibility of sending a convening notice by electronic means in accordance with Section 2:113(4) DCC.

 

GENERAL MEETING - PROCEDURAL RULES

 

Article 27

 

27.1                       The General Meeting shall be chaired by one of the following individuals, taking into account the following order of priority:

 

a.                                     by the Chairman, if there is a Chairman and he is present at the General Meeting;

 

b.                                     by another Supervisory Director who is chosen by the Supervisory Directors present at the General Meeting from their midst;

 

c.                                      by the CEO, if there is a CEO and he is present at the General Meeting;

 

d.                                     by another Managing Director who is chosen by the Managing Directors present at the General Meeting from their midst; or

 

e.                                      by another person appointed by the General Meeting.

 

The person who should chair the General Meeting pursuant to paragraphs a. through e. may appoint another person to chair the General Meeting instead of him.

 

27.2                       The chairman of the General Meeting shall appoint another person present at the General Meeting to act as secretary and to minute the proceedings at the General Meeting. The minutes of a General Meeting shall be adopted by the chairman of that General Meeting or by the Management Board. Where an official report of the proceedings is drawn up by a civil law notary, no minutes need to be prepared. Every Managing Director and Supervisory

 

19


 

Director may instruct a civil law notary to draw up such an official report at the Company’s expense.

 

27.3                       The chairman of the General Meeting shall decide on the admittance to the General Meeting of persons other than:

 

a.                                     the persons who have Meeting Rights at that General Meeting, or their proxyholders; and

 

b.                                     those who have a statutory right to attend that General Meeting on other grounds.

 

27.4                       The holder of a written proxy from a Person with Meeting Rights who is entitled to attend a General Meeting shall only be admitted to that General Meeting if the proxy is determined to be acceptable by the chairman of that General Meeting.

 

27.5                       The Company may direct that any person, before being admitted to a General Meeting, identify himself by means of a valid passport or driver’s license and/or should be submitted to such security arrangements as the Company may consider to be appropriate under the given circumstances. Persons who do not comply with these requirements may be refused entry to the General Meeting.

 

27.6                       The chairman of the General Meeting has the right to eject any person from the General Meeting if he considers that person to disrupt the orderly proceedings at the General Meeting.

 

27.7                       The General Meeting may be conducted in a language other than the Dutch language, if so determined by the chairman of the General Meeting.

 

27.8                       The chairman of the General Meeting may limit the amount of time that persons present at the General Meeting are allowed to take in addressing the General Meeting and the number of questions they are allowed to raise, with a view to safeguarding the orderly proceedings at the General Meeting. The chairman of the General Meeting may also adjourn the meeting if he considers that this shall safeguard the orderly proceedings at the General Meeting.

 

GENERAL MEETING - EXERCISE OF MEETING AND VOTING RIGHTS

 

Article 28

 

28.1                       Each Person with Meeting Rights has the right to attend, address and, if applicable, vote at General Meetings, whether in person or represented by the holder of a written proxy. Holders of fractional shares which collectively constitute the nominal value of a share shall exercise these rights collectively, whether through one of them or through the holder

 

20


 

of a written proxy.

 

28.2                       The Management Board may decide that each Person with Meeting Rights is entitled, whether in person or represented by the holder of a written proxy, to participate in, address and, if applicable, vote at the General Meeting by electronic means of communication. For the purpose of applying the preceding sentence it must be possible, by electronic means of communication, for the Person with Meeting Rights to be identified, to observe in real time the proceedings at the General Meeting and, if applicable, to vote. The Management Board may impose conditions on the use of the electronic means of communication, provided that these conditions are reasonable and necessary for the identification of the Person with Meeting Rights and the reliability and security of the communication. Such conditions must be announced in the convening notice.

 

28.3                       The Management Board can also decide that votes cast through electronic means of communication or by means of a letter prior to the General Meeting are considered to be votes that are cast during the General Meeting. These votes shall not be cast prior to the Record Date.

 

28.4                       For the purpose of Articles 28.1 through 28.3, those who have voting rights and/or Meeting Rights on the Record Date and are recorded as such in a register designated by the Management Board shall be considered to have those rights, irrespective of whoever is entitled to the shares or depository receipts at the time of the General Meeting. Unless Dutch law requires otherwise, the Management Board is free to determine, when convening a General Meeting, whether the previous sentence applies.

 

28.5                       Each Person with Meeting Rights must notify the Company in writing of his identity and his intention to attend the General Meeting. This notice must be received by the Company ultimately on the seventh day prior to the General Meeting, unless indicated otherwise when such General Meeting is convened. Persons with Meeting Rights that have not complied with this requirement may be refused entry to the General Meeting.

 

GENERAL MEETING - DECISION-MAKING

 

Article 29

 

29.1                       Each share shall give the right to cast one vote at the General Meeting. Fractional shares, if any, which collectively constitute the nominal value of a share shall be considered to be equivalent to such share.

 

29.2                       No vote may be cast at a General Meeting in respect of a share belonging to the Company or a Subsidiary or in respect of a share for which any of them holds the depository receipts. Usufructuaries and pledgees of shares belonging to the Company or its Subsidiaries are not, however, precluded from exercising their voting rights if the usufruct or pledge was created before the relevant share belonged to the Company or a Subsidiary. Neither the Company nor a Subsidiary may vote shares in respect of which it holds a usufruct or a pledge.

 

21


 

29.3                       Unless a greater majority is required by law or by these articles of association, all resolutions of the General Meeting shall be passed by Simple Majority. If applicable law requires a greater majority for resolutions of the General Meeting and allows the articles of association to provide for a lower majority, those resolutions shall be passed with the lowest possible majority, except if these articles of association explicitly provide otherwise.

 

29.4                       Invalid votes, blank votes and abstentions shall not be counted as votes cast. Shares in respect of which an invalid or blank vote has been cast and shares in respect of which an abstention has been made shall be taken into account when determining the part of the issued share capital that is represented at a General Meeting.

 

29.5                       Where there is a tie in any vote of the General Meeting, the relevant resolution shall not have been passed.

 

29.6                       The chairman of the General Meeting shall decide on the method of voting and the voting procedure at the General Meeting.

 

29.7                       The determination during the General Meeting made by the chairman of that General Meeting with regard to the results of a vote shall be decisive. If the accuracy of the chairman’s determination is contested immediately after it has been made, a new vote shall take place if the majority of the General Meeting so requires or, where the original vote did not take place by response to a roll call or in writing, if any party with voting rights who is present so requires. The legal consequences of the original vote shall lapse as a result of the new vote.

 

29.8                       The Management Board shall keep a record of the resolutions passed. The record shall be available at the Company’s office for inspection by Persons with Meeting Rights. Each of them shall, upon request, be provided with a copy of or extract from the record, at no more than the cost price.

 

29.9                       Shareholders may pass resolutions outside a meeting, unless the Company has cooperated with the issuance of depository receipts for shares in its capital. Such resolutions can only be passed by a unanimous vote of all shareholders with voting rights. The votes shall be cast in writing and may be cast through electronic means.

 

29.10                The Managing Directors and Supervisory Directors shall, in that capacity, have an advisory vote at the General Meetings.

 

GENERAL MEETING - SPECIAL RESOLUTIONS

 

Article 30

 

30.1                       The following resolutions can only be passed by the General Meeting at the proposal of the Management Board:

 

a.                                     the issue of shares or the granting of rights to subscribe for shares;

 

b.                                     the limitation or exclusion of pre-emption rights;

 

c.                                      the designation or granting of an authorisation as referred to in Articles 6.1, 7.5 and 10.2, respectively;

 

22


 

d.                                     the reduction of the Company’s issued share capital;

 

e.                                      the making of a distribution from the Company’s profits or reserves;

 

f.                                       the making of a distribution in the form of shares in the Company’s capital or in the form of assets, instead of in cash;

 

g.                                     the amendment of these articles of association;

 

h.                                     the entering into of a merger or demerger;

 

i.                                        the instruction of the Management Board to apply for the Company’s bankruptcy; and

 

j.                                        the Company’s dissolution.

 

30.2                       A matter which has been included in the convening notice or announced in the same manner by or at the request of one or more Persons with Meeting Rights pursuant to Articles 26.5 and/or 26.6 shall not be considered to have been proposed by the Management Board for purposes of Article 30.1, unless the Management Board has expressly indicated that it supports the discussion of such matter in the agenda of the General Meeting concerned or in the explanatory notes thereto.

 

REPORTING - FINANCIAL YEAR, ANNUAL ACCOUNTS AND MANAGEMENT REPORT

 

Article 31

 

31.1                       The Company’s financial year shall coincide with the calendar year.

 

31.2                       Annually, within the relevant statutory period, the Management Board shall prepare the annual accounts and the management report and deposit them at the Company’s office for inspection by the shareholders.

 

31.3                       The annual accounts shall be signed by the Managing Directors and the Supervisory Directors. If any of their signatures is missing, this shall be mentioned, stating the reasons.

 

31.4                       The Company shall ensure that the annual accounts, the management report and the particulars to be added pursuant to Section 2:392(1) DCC shall be available at its offices as from the convening of the General Meeting at which they are to be discussed. The Persons with Meeting Rights are entitled to inspect such documents at that location and to obtain a copy at no cost.

 

31.5                       The annual accounts shall be adopted by the General Meeting.

 

23


 

REPORTING - AUDIT

 

Article 32

 

32.1                       The General Meeting shall instruct an external auditor as referred to in Section 2:393 DCC to audit the annual accounts. Where the General Meeting fails to do so, the Supervisory Board shall be authorised to do so.

 

32.2                       The instruction may be revoked by the General Meeting and by the body that has granted the instruction. The instruction can only be revoked for well-founded reasons; a difference of opinion regarding the reporting or auditing methods shall not constitute such a reason.

 

DISTRIBUTIONS - GENERAL

 

Article 33

 

33.1                       A distribution can only be made to the extent that the Company’s equity exceeds the amount of the paid up and called up part of its capital plus the reserves which must be maintained by law.

 

33.2                       The Management Board may resolve to make interim distributions, provided that it appears from interim accounts to be prepared in accordance with Section 2:105(4) DCC that the requirement referred to in Article 33.1 has been met.

 

33.3                       Distributions shall be made in proportion to the aggregate nominal value of the shares.

 

33.4                       The parties entitled to a distribution shall be the relevant shareholders, usufructuaries and pledgees, as the case may be, at a date to be determined by the Management Board for that purpose. This date shall not be earlier than the date on which the distribution was announced.

 

33.5                       The General Meeting may resolve, subject to Article 30, that all or part of a distribution, instead of being made in cash, shall be made in the form of shares in the Company’s capital or in the form of the Company’s assets.

 

33.6                       A distribution shall be payable on such date and, if it concerns a distribution in cash, in such currency or currencies as determined by the Management Board. If it concerns a distribution in the form of the Company’s assets, the Management Board shall determine the value attributed to such distribution for purposes of recording the distribution in the Company’s accounts with due observance of applicable law (including the applicable accounting principles).

 

33.7                       A claim for payment of a distribution shall lapse after five years have expired after the distribution became payable.

 

33.8                       For the purpose of calculating the amount or allocation of any distribution, shares held by the Company in its own capital shall not be taken into account. No distribution shall be

 

24


 

made to the Company in respect of shares held by it in its own capital.

 

DISTRIBUTIONS - PROFITS AND RESERVES

 

Article 34

 

34.1                       Subject to Article 33.1, the profits shown in the Company’s annual accounts in respect of a financial year shall be appropriated as follows, and in the following order of priority:

 

a.                                     the Management Board shall determine which part of the profits shall be added to the Company’s reserves; and

 

b.                                     subject Article 30, the remaining profits shall be at the disposal of the General Meeting for distribution on the shares.

 

34.2                       Subject to Article 33.1, a distribution of profits shall be made after the adoption of the annual accounts that show that such distribution is allowed.

 

34.3                       Subject to Article 30, the General Meeting is authorised to resolve to make a distribution from the Company’s reserves.

 

34.4                       The Management Board may resolve to charge amounts to be paid up on shares against the Company’s reserves, irrespective of whether those shares are issued to existing shareholders.

 

DISSOLUTION AND LIQUIDATION

 

Article 35

 

35.1                       In the event of the Company being dissolved, the liquidation shall be effected by the Management Board under the supervision of the Supervisory Board, unless the General Meeting decides otherwise.

 

35.2                       To the extent possible, these articles of association shall remain in effect during the liquidation.

 

35.3                       Any assets remaining after payment of all of the Company’s debts shall be distributed to the shareholders.

 

35.4                       After the Company has ceased to exist, its books, records and other information carriers shall be kept for the period prescribed by law by the person designated for that purpose in the resolution of the General Meeting to dissolve the Company. Where the General Meeting has not designated such a person, the liquidators shall do so.

 

25


 

TRANSITIONAL PROVISION

 

Article 36

 

36.1                       The Company’s first financial year ends on the thirty-first day of December two thousand and nineteen.

 

26


Exhibit 5.1

 

ATTORNEYS • CIVIL LAW NOTARIES • TAX ADVISERS

 

 

P.O. Box 7113

 

1007 JC Amsterdam

Amsterdam, November 6, 2019.

Beethovenstraat 400

 

1082 PR Amsterdam

To the Company

T +31 20 71 71 000

 

F +31 20 71 71 111

 

 

 

 

 

 

Amsterdam

 

Brussels

 

London

 

Luxemburg

 

New York

 

Rotterdam

 

 

Ladies and Gentlemen:

 

We have acted as legal counsel as to Netherlands law to the Company in connection with the Registration Statement and the filing thereof with the SEC. This opinion letter is rendered to you in order to be filed with the SEC as an exhibit to the Registration Statement.

 

Capitalised terms used in this opinion letter have the meanings set forth in Exhibit A to this opinion letter. The section headings used in this opinion letter are for convenience of reference only and are not to affect its construction or to be taken into consideration in its interpretation.

 

This opinion letter is strictly limited to the matters stated in it and may not be read as extending by implication to any matters not specifically referred to in it. Nothing in this opinion letter should be taken as expressing an opinion in respect of any representations or warranties, or other information, contained in the Reviewed Documents.

 

In rendering the opinions expressed in this opinion letter, we have reviewed and relied upon drafts of the Reviewed Documents and pdf copies or drafts, as the case may be, of the Corporate Documents and we have assumed that any grant of Awards and any issuance of Plan Shares shall be effected for bona fide commercial reasons. We have not investigated or verified any factual matter disclosed to us in the course of our review.

 

This opinion letter sets out our opinion on certain matters of the laws with general applicability of the Netherlands, and, insofar as they are directly applicable in the Netherlands, of the European Union, as at today’s date and as presently interpreted under published authoritative case law of the Netherlands courts, the General Court and the Court of Justice of the European Union. We do not express any opinion on Netherlands or European competition law, tax law or regulatory law. No undertaking is assumed on our part to revise, update or amend this opinion letter in connection with or to notify or inform you of, any developments and/or changes of Netherlands law subsequent to today’s date. We do not purport

 

This communication is confidential and may be subject to professional privilege. All legal relationships are subject to NautaDutilh N.V.’s general terms and conditions (see https://www.nautadutilh.com/terms), which apply mutatis mutandis to our relationship with third parties relying on statements of NautaDutilh N.V., include a limitation of liability clause, have been filed with the Rotterdam District Court and will be provided free of charge upon request. NautaDutilh N.V.; corporate seat Rotterdam; trade register no. 24338323.

 


 

to opine on the consequences of amendments to the Reviewed Documents or the Corporate Documents subsequent to the date of this opinion letter.

 

The opinions expressed in this opinion letter are to be construed and interpreted in accordance with Netherlands law. The competent courts at Amsterdam, the Netherlands, have exclusive jurisdiction to settle any issues of interpretation or liability arising out of or in connection with this opinion letter. Any legal relationship arising out of or in connection with this opinion letter (whether contractual or non-contractual), including the above submission to jurisdiction, is governed by Netherlands law and shall be subject to the general terms and conditions of NautaDutilh. Any liability arising out of or in connection with this opinion letter shall be limited to the amount which is paid out under NautaDutilh’s insurance policy in the matter concerned. No person other than NautaDutilh may be held liable in connection with this opinion letter.

 

In this opinion letter, legal concepts are expressed in English terms. The Netherlands legal concepts concerned may not be identical in meaning to the concepts described by the English terms as they exist under the law of other jurisdictions. In the event of a conflict or inconsistency, the relevant expression shall be deemed to refer only to the Netherlands legal concepts described by the English terms.

 

For the purposes of this opinion letter, we have assumed that:

 

a.                                      drafts of documents reviewed by us will be signed in the form of those drafts, each copy of a document conforms to the original, each original is authentic, and each signature is the genuine signature of the individual purported to have placed that signature;

 

b.                                      the Registration Statement has been declared effective by the SEC in the form of the draft reviewed by us;

 

c.                                       the Current Articles are the Articles of Association currently in force and the Revised Articles are the Articles of Association as they will be in force at each Relevant Moment;

 

d.                                      at each Relevant Moment, the resolutions recorded in the Resolution are in full force and effect, the factual statements made and the confirmations given in the Resolution are complete and correct and the Resolution correctly reflects the resolutions recorded therein;

 

e.                                       at each Relevant Moment, the Company will not (i) have been dissolved (ontbonden), (ii) have ceased to exist pursuant to a merger (fusie) or a

 

2


 

division (splitsing), (iii) have been converted (omgezet) into another legal form, either national or foreign, (iv) have had its assets placed under administration (onder bewind gesteld), (v) have been declared bankrupt (failliet verklaard), (vi) have been granted a suspension of payments (surseance van betaling verleend), or (vii) have been made subject to similar proceedings in any jurisdiction or otherwise been limited in its power to dispose of its assets;

 

f.                                        at each Relevant Moment, (i) the relevant Award(s) shall have been validly granted as a right to subscribe for Common Shares (recht tot het nemen van aandelen), (ii) shall be in full force and effect upon being exercised, (iii) shall have been validly exercised in accordance with the terms and conditions applicable to such Award(s) and (iv) any pre-emption rights in respect of such Award(s) shall have been validly excluded by the corporate body authorized to do so;

 

g.                                       at each Relevant Moment, each holder of the relevant Award(s) shall be an individual who has not (i) deceased, (ii) had his/her assets placed under administration (onder bewind gesteld), (iii) been declared bankrupt (failliet verklaard), (iv) been granted a suspension of payments (surseance van betaling verleend), or (v) been made subject to similar proceedings in any jurisdiction or otherwise been limited in the power to dispose of his/her assets; and

 

h.                                      at each Relevant Moment, the authorised share capital (maatschappelijk kapitaal) of the Company shall allow for the grant of Awards and the issuance of Plan Shares pursuant to the exercise thereof.

 

Based upon and subject to the foregoing and subject to the qualifications set forth in this opinion letter and to any matters, documents or events not disclosed to us, we express the following opinions:

 

Corporate Status

 

1.                                     The Company has been duly incorporated as a besloten vennootschap met beperkte aansprakelijkheid and, upon the execution of the Deed of Conversion, shall be validly existing as a naamloze vennootschap.

 

Plan Shares

 

2.                                     Subject to receipt by the Company of payment in full for (or other satisfaction of the issue price of) the Plan Shares in accordance with the Plan, and when issued and accepted in accordance with the Plan, the Plan

 

3


 

Shares will be validly issued, fully paid and non-assessable.

 

The opinions expressed above are subject to the following qualifications:

 

A.                                   Opinion 1 must not be read to imply that the Company cannot be dissolved (ontbonden). A company such as the Company may be dissolved, inter alia by the competent court at the request of the company’s board of directors, any interested party (belanghebbende) or the public prosecution office in certain circumstances, such as when there are certain defects in the incorporation of the company. Any such dissolution will not have retro-active effect.

 

B.                                   Pursuant to Section 2:7 NCC, any transaction entered into by a legal entity may be nullified by the legal entity itself or its liquidator in bankruptcy proceedings (curator) if the objects of that entity were transgressed by the transaction and the other party to the transaction knew or should have known this without independent investigation (wist of zonder eigen onderzoek moest weten). The Netherlands Supreme Court (Hoge Raad der Nederlanden) has ruled that in determining whether the objects of a legal entity are transgressed, not only the description of the objects in that legal entity’s articles of association (statuten) is decisive, but all (relevant) circumstances must be taken into account, in particular whether the interests of the legal entity were served by the transaction. Based on the objects clauses contained in the Current Articles and in the Revised Articles, we have no reason to believe that, by granting Awards or by issuing Plan Shares, the Company would transgress the description of the objects contained in its Articles of Association. However, we cannot assess whether there are other relevant circumstances that must be taken into account, in particular whether the interests of the Company are served by granting Awards or issuing Plan Shares since this is a matter of fact.

 

C.                                   Pursuant to Section 2:98c NCC, a naamloze vennootschap may grant loans (leningen verstrekken) only in accordance with the restrictions set out in Section 2:98c NCC, and may not provide security (zekerheid stellen), give a price guarantee (koersgarantie geven) or otherwise bind itself, whether jointly and severally or otherwise with or for third parties (zich op andere wijze sterk maken of zich hoofdelijk of anderszins naast of voor anderen verbinden) with a view to (met het oog op) the subscription or acquisition by third parties of shares in its share capital or depository receipts. This prohibition also applies to its subsidiaries (dochtervennootschappen). It is generally assumed that a transaction entered into in violation of Section 2:98c NCC is null and void (nietig).

 

4


 

Based on the content of the Reviewed Documents, we have no reason to believe that the Company or its subsidiaries will violate Section 2:98c NCC in connection with the issue of Plan Shares. However, we cannot confirm this definitively, since the determination of whether a company (or a subsidiary) has provided security, has given a price guarantee or has otherwise bound itself, with a view to the subscription or acquisition by third parties of shares in its share capital or depository receipts, as described above, is a matter of fact.

 

D.                                   The opinions expressed in this opinion letter may be limited or affected by:

 

a.                                     any applicable bankruptcy, insolvency, reorganisation, moratorium or other similar laws or procedures now or hereafter in effect, relating to or affecting the enforcement or protection of creditors’ rights generally;

 

b.                                     the provisions of fraudulent preference and fraudulent conveyance (Actio Pauliana) and similar rights available in other jurisdictions to liquidators in bankruptcy proceedings or creditors;

 

c.                                      claims based on tort (onrechtmatige daad);

 

d.                                     sanctions and measures, including but not limited to those concerning export control, pursuant to European Union regulations, under the Sanctions Act 1977 (Sanctiewet 1977) or other legislation;

 

e.                                      the Anti-Boycott Regulation and related legislation; and

 

f.                                       the rules of force majeure (niet toerekenbare tekortkoming), reasonableness and fairness (redelijkheid en billijkheid), suspension (opschorting), dissolution (ontbinding), unforeseen circumstances (onvoorziene omstandigheden) and vitiated consent (i.e., duress (bedreiging), fraud (bedrog), abuse of circumstances (misbruik van omstandigheden) and error (dwaling)) or a difference of intention (wil) and declaration (verklaring).

 

E.                                    The term “non-assessable” has no equivalent in the Dutch language and for purposes of this opinion letter such term should be interpreted to mean that a holder of a share will not by reason of merely being such a

 

5


 

holder be subject to assessment or calls by the Company or its creditors for further payment on such share.

 

F.                                     This opinion letter does not purport to express any opinion or view on the operational rules and procedures of any clearing or settlement system or agency.

 

We consent to the filing of this opinion letter as an exhibit to the Registration Statement. In giving this consent we do not admit or imply that we are a person whose consent is required under Section 7 of the United States Securities Act of 1933, as amended, or any rules and regulations promulgated thereunder

 

Sincerely yours,

 

 

/s/ NautaDutilh N.V.

 

NautaDutilh N.V.

 

 

6


 

EXHIBIT A

LIST OF DEFINITIONS

 

Anti-Boycott Regulation

 

The Council Regulation (EC) No 2271/96 of 22 November 1996 on protecting against the effects of the extra-territorial application of legislation adopted by a third country, and actions based thereon or resulting therefrom.

 

 

 

Articles of Association

 

The Company’s articles of association (statuten) as they read from time to time.

 

 

 

Awards

 

Rights to subscribe for Common Shares pursuant to the terms and conditions of the Plan, the Transfer Agreement and/or the Resolution, as applicable.

 

 

 

Commercial Register

 

The Netherlands Commercial Register (handelsregister).

 

 

 

Common Shares

 

Common shares in the Company’s capital, with a nominal value of EUR 0.12 each.

 

 

 

Company

 

Centogene B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), registered with the Commercial Register under number 72822872, and to be renamed Centogene N.V. pursuant to the Deed of Conversion.

 

 

 

Corporate Documents

 

The Deed of Incorporation, the Deed of Conversion, the Current Articles, the Revised Articles, the Resolution and the Registration Statement.

 

 

 

Current Articles

 

The Articles of Association as contained in the Deed of Incorporation.

 

 

 

Deed of Conversion

 

The draft deed of conversion and amendment to the Articles of Association prepared by us with reference number 82042626 M 25004107.

 

 

 

Deed of Incorporation

 

The Company’s deed of incorporation (akte van oprichting), dated October 11, 2018.

 

7


 

General Meeting

 

The Company’s general meeting of shareholders (algemene vergadering van aandeelhouders).

 

 

 

NautaDutilh

 

NautaDutilh N.V.

 

 

 

NCC

 

The Netherlands Civil Code (Burgerlijk Wetboek).

 

 

 

the Netherlands

 

The European territory of the Kingdom of the Netherlands.

 

 

 

Plan

 

The draft Long-Term Incentive Plan of the Company in the form attached to the Resolution as an annex.

 

 

 

Plan Shares

 

805,308 Common Shares reserved for issuance under the Plan in order to settle the Company’s obligations under the draft Transfer Agreement and 2,581,975 Common Shares available for future issuance under the Plan.

 

 

 

Registration Statement

 

The Company’s registration statement on Form S-8 filed or to be filed with the SEC on or about the date of this opinion letter, in the form reviewed by us.

 

 

 

Relevant Moment

 

Each time that one or more Awards are granted or one or more Plan Shares are issued pursuant to the exercise of the relevant Award(s).

 

 

 

Resolution

 

The written resolution of the General Meeting, dated October 28, 2019.

 

 

 

Reviewed Documents

 

The Transfer Agreement and the Plan.

 

 

 

Revised Articles

 

The Articles of Association as they will read immediately after the execution of the Deed of Conversion.

 

 

 

SEC

 

The United States Securities and Exchange Commission.

 

8


 

Transfer Agreement

 

The draft Transfer Agreement for the Employee Incentive Program 2016 of Centogene AG in the form attached to the Resolution as an annex.

 

9


Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on November 6, 2019 pertaining to the Centogene N.V. Long-Term Incentive Plan of our report dated March 28, 2019, with respect to the consolidated financial statements of Centogene AG, included in the Registration Statement (Form F-1, No. 333-234177) of Centogene B.V., filed with the Securities and Exchange Commission.

 

/s/Ingo Röders

/s/Christian Patzelt

Wirtschaftsprüfer

Wirtschaftsprüfer

(German Public Auditor)

(German Public Auditor)

 

Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft

Berlin, Germany

 

November 6, 2019

 


Exhibit 99.1

 

 

LONG-TERM INCENTIVE PLAN

 

CENTOGENE N.V.

 

Dated November 6, 2019

 

INTRODUCTION

 

Article 1

 

1.1                              This document sets out the Company’s long-term incentive plan for employees, officers and other service providers who qualify as Eligible Participants.

 

1.2                              The main purposes of this Plan are:

 

a.                                     to attract, retain and motivate Participants with the qualities, skills and experience needed to support and promote the growth and sustainable success of the Company and its business; and

 

b.                                     to incentivise Participants to perform at the highest level and to further the best interests of the Company, its business and its stakeholders.

 

DEFINITIONS AND INTERPRETATION

 

Article 2

 

2.1                              In this Plan the following definitions shall apply:

 

Article

 

An article of this Plan.

 

 

 

Award

 

A grant under this Plan in the form of one or more Options, SARs, Shares of Restricted Stock, RSUs, Other Awards, or a combination of the foregoing.

 

 

 

Award Agreement

 

A written agreement between the Company and a Participant evidencing the grant of an Award to such Participant and containing such terms as the Committee may determine, consistent with and subject to the terms of this Plan.

 

 

 

Bad Leaver

 

A Participant who ceases to be an Eligible Participant for Cause.

 

 

 

Cause

 

With respect to a Participant, “cause” as defined in such Participant’s employment, service or consulting agreement with the Company or a Subsidiary, or if not so defined (and unless determined otherwise in the applicable Award Agreement or otherwise by the Committee):

 

a.                                      such Participant’s indictment for any crime which (i) constitutes a felony, (ii) has, or could

 

1


 

 

 

reasonably be expected to have, an adverse impact on the performance of such Participant’s services to the Company and/or any Subsidiary or (iii) has, or could reasonably be expected to have, an adverse impact on the business and/or reputation of the Company and/or any Subsidiary;

 

b.                                      such Participant having been the subject of any order, judicial or administrative, obtained or issued by any governmental or regulatory body for any securities laws violation involving fraud, market manipulation, insider trading and/or unlawful dissemination of non-public price-sensitive information;

 

c.                                       such Participant’s wilful violation of the Company’s code of business conduct and ethics, insider trading policy or other internal policies and regulations established by the Company and/or any Subsidiary, in each case to the extent applicable to the Participant concerned;

 

d.                                      gross negligence or wilful misconduct in the performance of such Participant’s duties for the Company and/or any Subsidiary or wilful or repeated failure or refusal to perform such duties; e. material breach by such Participant of any employment, service, consulting or other agreement entered into between such Participant on the one hand and the Company and/or any Subsidiary on the other;

 

f.                                        conduct by such Participant which should be considered as an urgent cause within the meaning of Section 7:678 DCC, irrespective of whether that provision applies to such Participant’s relationship with the Company and/or any Subsidiary; and

 

g.                                      such other acts or omissions to act by such Participant as reasonably determined by the Committee,

 

provided that the Committee may determine, at its absolute discretion, that occurrence of an event described in paragraphs c. through e. above shall only constitute

 

2


 

 

 

Cause if and when such event has not been cured or remedied by the relevant Participant within thirty days after the Company has provided written notice to such Participant.

 

 

 

Change of Control

 

The occurrence of any one or more of the following events:

 

a.                                      the direct or indirect change in ownership or control of the Company effected through one transaction, or a series of related transactions within a twelve-month period, as a result of which any Person or group of Persons acting in concert, directly or indirectly acquires (i) beneficial ownership of more than half of the Company’s issued share capital and/or (ii) the ability to cast more than half of the voting rights in the General Meeting;

 

b.                                      at any time during a period of twelve consecutive months, individuals who at the beginning of such period constituted the Supervisory Board cease to constitute a majority of members of the Supervisory Board, provided that any new member of the Supervisory Board who was nominated for appointment by the Supervisory Board by a vote of at least a majority of the Supervisory Directors who either were Supervisory Directors at the beginning of such twelve-month period or whose nomination for appointment was so approved, shall be considered as though such individual were a member of the Supervisory Board at the beginning of such twelve-month period;

 

c.                                       the consummation of a merger, demerger or business combination of the Company or any Subsidiary with another Person, unless such transaction results in the Shares outstanding immediately prior to the consummation of such transaction continuing to represent (either by remaining outstanding or by being converted into, or exchanged for, voting securities of the

 

3


 

 

 

surviving or acquiring Person or a parent thereof) at least half of the voting rights in the General Meeting or in the shareholders’ meeting of such surviving or acquiring Person or parent outstanding immediately after the consummation of such transaction; or

 

 

 

 

 

d.                                      the consummation of any sale, lease, exchange or other transfer to any Person or group of Persons acting in concert, not being Subsidiaries, in one transaction or a series of related transactions within a twelve-month period, of all or substantially all of the business of the Company and its Subsidiaries.

 

 

 

Committee

 

Either of the following bodies, as applicable:

 

a.                                      the Management Board, to the extent the administration or operation of this Plan relates to the grant of Awards to Eligible Participants who are not Managing Directors or Supervisory Directors, as well as any other matter relating to such Awards, provided that (i) the Management Board may not grant more Awards to those Eligible Participants than an aggregate number of Awards approved by the Supervisory Board, at the recommendation of the Company's compensation committee, from time to time and (ii) when granting such Awards, the Management Board shall observe any other restrictions imposed by the Supervisory Board from time to time in connection with the administration or operation of this Plan;

 

b.                                      the Supervisory Board, at the recommendation of the Company's compensation committee, for all other matters relating to the administration or operation of the Plan, including – for the avoidance of doubt – for matters in respect of which the Management Board is not authorized for the administration or operation of the Plan under paragraph a. above, provided that (i) the Company's compensation committee may, but is not required to, provide recommendations concerning the granting of Awards to members of the Company's compensation committee and (ii) the Management Board shall implement decisions by the Supervisory Board made pursuant to this paragraph b.

 

 

 

Company

 

Centogene N.V.

 

 

 

Consultant

 

Any Person, other than a Managing Director, Supervisory Director or Employee, who is an adviser or consultant engaged by the Company and/or a Subsidiary to render bona fide services to the Company and/or a Subsidiary.

 

 

 

DCC

 

The Dutch Civil Code.

 

 

 

Eligible Participant

 

Any Managing Director, Supervisory Director, Employee or Consultant.

 

 

 

Employee

 

Any Person, other than a Managing Director or a Supervisory

 

4


 

 

 

Director, who is an employee or officer of the Company and/or a Subsidiary.

 

 

 

Exercise Date

 

The date on which an Award is duly exercised by or on behalf of the Participant concerned.

 

 

 

Exercise Price

 

The exercise price applicable to an Award.

 

 

 

FMV

 

The volume weighted average closing price of a Share over a period of twenty trading days on the principal stock exchange where Shares have been admitted for trading, unless determined otherwise by the Committee.

 

 

 

General Meeting

 

The Company’s general meeting of shareholders.

 

 

 

Good Leaver

 

A Participant who ceases to be an Eligible Participant and who is not a Bad Leaver.

 

 

 

Grant Date

 

The date on which the Committee decides to grant an Award, or such later effective date applicable to such Award as may be determined by the Committee.

 

 

 

Management Board

 

The Company’s management board.

 

 

 

Managing Director

 

A member of the Management Board.

 

 

 

Option

 

The right to subscribe for, or otherwise acquire, one Plan Share.

 

 

 

Other Award

 

An Award which does not take the form of an Option, SAR, Share of Restricted Stock or RSU, and which may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to Shares or factors which may influence the value of Shares, including cash-settled financial instruments and financial instruments which are convertible into or exchangeable for Plan Shares.

 

 

 

Participant

 

The holder of an Award, including, as the context may require, the rightful heir(s) of a previous holder of such Award having acquired such Award as a result of the death of such previous holder.

 

 

 

Performance Criteria

 

The performance criteria applicable to an Award.

 

 

 

Person

 

A natural person, partnership, company, association, cooperative, mutual insurance society, foundation or any other entity or body which operates externally as an

 

5


 

 

 

independent unit or organisation.

 

 

 

Plan

 

This long-term incentive plan.

 

 

 

Plan Share

 

A Share underlying an Award.

 

 

 

Replacement Award

 

An Award granted in assumption of, or in substitution or exchange for, long-term incentive awards previously granted by a Person acquired (or whose business is acquired) by the Company or a Subsidiary or with which the Company or a Subsidiary merges or forms a business combination, as reasonably determined by the Committee.

 

 

 

Restricted Stock

 

Plan Shares subject to such restrictions as the Committee may impose, including with respect to voting rights and the right to receive dividends or other distributions made by the Company.

 

 

 

RSU

 

The right to receive, in cash, in assets, in the form of Plan Shares valued at FMV, or a combination thereof, the FMV of one Share on the Exercise Date.

 

 

 

SAR

 

The right to receive, in cash, in assets, in the form of Plan Shares valued at FMV, or a combination thereof, the excess of the FMV of one Share on the applicable Exercise Date over the applicable Exercise Price.

 

 

 

Section 409A IRC

 

Section 409A of the United States Internal Revenue Code of 1986, as amended, and the rules, regulations and guidance promulgated pursuant thereto.

 

 

 

Share

 

A share in the Company’s capital.

 

 

 

Subsidiary

 

A subsidiary of the Company within the meaning of Section 2:24a DCC.

 

 

 

Supervisory Board

 

The Company’s supervisory board.

 

 

 

Supervisory Director

 

A member of the Supervisory Board.

 

2.2                              References to statutory provisions are to those provisions as they are in force from time to time.

 

2.3                              Terms that are defined in the singular have a corresponding meaning in the plural.

 

2.4                              Words denoting a gender include each other gender.

 

2.5                              Except as otherwise required by law, the terms “written” and “in writing” include the use of electronic means of communication.

 

6


 

ADMINISTRATION

 

Article 3

 

3.1                              This Plan shall be administered by the Committee. The Committee’s powers and authorities under this Plan include the authority to perform the following matters, in each case consistent with and subject to the terms of this Plan:

 

a.                                     designating Persons to whom Awards are granted;

 

b.                                     deciding to grant Awards;

 

c.                                      determining the form(s) and type(s) of Awards being granted and setting the terms and conditions applicable to such Awards, including:

 

i.                                        the number of Plan Shares underlying Awards;

 

ii.                                    whether, to which extent, and under which circumstances Awards may be exercised or settled in cash or assets (including other Awards), or some combination thereof, in lieu of Plan Shares and vice versa, or cancelled, forfeited or suspended;

 

iii.                                whether, to which extent and under which circumstances a Participant may designate another Person owned or controlled by him as recipient or beneficiary of his Awards;

 

iv.                                 whether and to which extent Awards are subject to Performance Criteria and/or restrictive covenants (including non-competition, non-solicitation, confidentiality and/or Share ownership requirements);

 

v.                                     the method(s) by which Awards may be exercised, settled or cancelled;

 

vi.                                 whether, to which extent and under which circumstances, the exercise, settlement or cancellation of Awards may be deferred or suspended;

 

d.                                     amending or waiving the terms applicable to outstanding Awards (including Performance Criteria), subject to the restrictions imposed by Article 9 and provided that no such amendment shall take effect without the consent of the affected Participant(s), if such amendment would materially and adversely affect the rights of the Participant(s) under such Awards, except to the extent that any such amendment is made to cause this Plan or the Awards concerned to comply with applicable law, stock exchange rules, accounting principles or tax rules and regulations;

 

e.                                      correcting any defect, supplying any omission or reconciling any inconsistency in the Plan or any Award Agreement;

 

f.                                       making any determination under, and interpreting the terms of, this Plan, any rules or regulations issued pursuant to this Plan and any Award Agreement;

 

g.                                     settling any dispute between the Company and any Participant (including any beneficiary of his Awards) regarding the administration and operation of this Plan,

 

7


 

any rules or regulations issued pursuant to this Plan, and any Award Agreement entered into with such Participant; and

 

h.                                     making any other determination or taking any other action which the Committee considers to be necessary, useful or desirable in connection with the administration or operation of this Plan.

 

3.2                              The Committee may issue further rules and regulations for the administration and operation of this Plan, consistent with and subject to the terms of this Plan.

 

3.3                              All decisions of the Committee shall be final, conclusive and binding upon the Company and the Participants (including beneficiaries of Awards).

 

AWARDS

 

Article 4

 

4.1                              Awards can only be granted to Eligible Participants, unless the Committee decides otherwise.

 

4.2                              No Award is intended to confer any rights on the relevant Participant except as set forth in the applicable Award Agreement. In particular, no Award should be construed as giving any Participant the right to remain employed by or to continue to provide services for the Company or any Subsidiary.

 

4.3                              Awards shall be granted for no consideration or for such minimal cash consideration as may be required by applicable law.

 

4.4                              Awards may be granted alone or in addition or in tandem with any other Award and/or any award under any other plan of the Company or any Subsidiary. Awards granted in addition or in tandem with any other Award and/or any award under any other plan of the Company or any Subsidiary may be granted simultaneously or at different times.

 

4.5                              Each Award shall be evidenced by an Award Agreement entered into between the Company and the Participant concerned. Until an Award Agreement has been entered into between the Company and the relevant Participant, no rights can be derived from the Awards concerned by such Participant.

 

4.6                              Plan Shares, including Awards in the form of Shares of Restricted Stock, shall be delivered in such form(s) as may be determined by the Committee and shall be subject to such stop transfer orders and other restrictions as the Committee may deem required or advisable. Furthermore, the Committee may determine that certificates for such Shares shall bear an appropriate legend referring to the terms, conditions and restrictions applicable thereto.

 

4.7                              The terms and conditions applicable to Awards, including the time(s) when Awards vest in whole or in part and any applicable Performance Criteria, shall be set by the Committee and may vary between Awards and between Participants, as the Committee deems appropriate. The Committee may also determine whether and under which circumstances

 

8


 

Awards shall be settled automatically upon vesting, without being exercised by the Participant.

 

4.8                              The term of an Award shall be determined by the Committee, but shall not exceed ten years from the applicable Grant Date. Unless determined otherwise by the Committee, if the exercise of an Award is prohibited by applicable law or the Company’s insider trading policy on the last business day of the term of such Award, such term shall be extended for a period of one month following the end of such prohibition.

 

4.9                              Unless determined otherwise by the Committee, Awards cannot be transferred, pledged or otherwise encumbered, except by testament or hereditary law as a result of death of the Participant concerned.

 

4.10                       If, as a result of changes in applicable law, accounting principles or tax rules and regulations, or due to a variation of the composition of the Company’s issued share capital (including a share split, reverse share split, redenomination of the nominal value, or as a result of a dividend or other distribution, reorganization, acquisition, merger, demerger, business combination or other transaction involving the Company or a Subsidiary), an adjustment to this Plan, any Award Agreement and/or outstanding Awards is necessary to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this Plan, the Committee may adjust equitably any or all of:

 

a.                                     the number of Plan Shares available under this Plan;

 

b.                                     the number of Plan Shares underlying outstanding Awards; and/or

 

c.                                      the Exercise Price or other terms applicable to outstanding Awards.

 

4.11                       Any rights, payments and benefits under any Award shall be subject to repayment and/or recoupment by the Company in accordance with applicable law, stock exchange rules and such policies and procedures as the Company may adopt from time to time.

 

4.12                       The Company may withhold from any outstanding Award, any payment, issuance or transfer to be made under such Award, or any other compensation or amount owed by the Company to the Participant holding such Award, an amount (in cash, in assets, in the form of Shares or other Awards, or a combination thereof) equal to the withholding taxes and other costs due, or to be withheld, by the Company or any Subsidiary in respect of the grant, exercise or settlement of such Award.

 

TYPES OF AWARDS

 

Article 5

 

5.1                              The Committee may grant Awards in the form of Options, SARs, Shares of Restricted Stock, RSUs, Other Awards or a combination of the foregoing.

 

5.2                              Upon the exercise or settlement of vested Options, the Company shall be obliged to deliver to the Participant concerned (or the beneficiary of such Options, as applicable), the Plan

 

9


 

Shares underlying such Options (unless otherwise set forth in the Award Agreement).

 

5.3                              Upon the exercise or settlement of vested SARs, the Company shall be obliged to pay to the Participant concerned (or the beneficiary of such SARs, as applicable) an amount equal to the number of Plan Shares underlying such SARs multiplied by the excess, if any, of the FMV of one Share on the applicable Exercise Date over the applicable Exercise Price. The Company may satisfy such payment obligation in cash, in assets, in the form of Shares valued at FMV, or a combination thereof, at the discretion of the Committee.

 

5.4                              The exercise by a Participant of his rights attached to Shares of Restricted Stock shall be subject to such restrictions as the Committee may impose, including with respect to voting rights and the right to receive dividends or other distributions made by the Company. Upon the vesting of Shares of Restricted Stock, any such restrictions and conditions shall lapse with respect to those Shares. If an Award in the form of Shares of Restricted Stock is cancelled or otherwise terminated, the Participant shall be obliged to transfer all of his unvested Shares of Restricted Stock to the Company promptly and for no consideration.

 

5.5                              Upon the exercise or settlement of vested RSUs, the Company shall be obliged to pay to the Participant concerned (or the beneficiary of such RSUs, as applicable) an amount equal to the number of Plan Shares underlying such RSUs multiplied by the FMV of one Share on the applicable Exercise Date. The Company may satisfy such payment obligation in cash, in assets, in the form of Shares valued at FMV, or a combination thereof, at the discretion of the Committee (unless otherwise set forth in the Award Agreement).

 

5.6                              The Committee may determine that a Participant holding one or more RSUs is entitled to receive dividends and other distributions made by the Company on the Shares, as if such Participant held the Plan Shares underlying such RSUs. The Committee may impose restrictions with respect to such entitlement.

 

PERFORMANCE CRITERIA

 

Article 6

 

6.1                              The Committee may condition the right of a Participant to exercise one or more of his Awards, and the timing thereof, upon the achievement or satisfaction of such Performance Criteria as may be determined by the Committee, within periods specified by the Committee.

 

6.2                              If an Award is subject to Performance Criteria which must be achieved or satisfied within a period specified by the Committee for that purpose, such Award can only be exercised or settled at or after the end of that period.

 

6.3                              Performance Criteria may be measured on an absolute or relative basis and may be established on a Company-wide basis or with respect to one or more business units, divisions, Subsidiaries and/or business segments. Relative performance may be measured against a group of peer companies determined by the Committee, financial market indices and/or

 

10


 

other objective and quantifiable indices. Performance Criteria may relate to performance by the Company and/or by the Participant concerned.

 

6.4                              If the Committee determines that a change in the business, operations, group structure or capital structure of the Company, or other events or circumstances, render certain Performance Criteria applicable to outstanding Awards unsuitable or inappropriate, the Committee may amend or waive such Performance Criteria, in whole or in part, as the Committee deems appropriate.

 

PLAN SHARES AVAILABLE FOR AWARDS

 

Article 7

 

7.1                              Subject to Articles 4.10 and 7.2, (i) the maximum number of Plan Shares underlying Awards which are not Replacement Awards shall not exceed 13% of the Company’s issued and outstanding share capital Shares as of the date of this Plan provided that, on January 1, 2020 and on January 1 of each calendar year thereafter, such maximum number shall be increased with an additional number of Shares equal to 3% of the Company’s issued share capital on such date (or any lower number of Shares as determined by the Committee).

 

7.2                              Plan Shares underlying Awards, except for Replacement Awards, which expire, which are cancelled or otherwise terminated, or which are exercised or settled in cash or assets in lieu of Plan Shares, shall again be available under this Plan and shall not be counted towards the limit imposed by Article 7.1.

 

VESTING, EXERCISE AND SETTLEMENT

 

Article 8

 

8.1                              Each Award Agreement shall contain the vesting schedule and, where relevant, delivery schedule (which may include deferred delivery later than the vesting dates) for the relevant Awards.

 

8.2                              Only vested Awards may be exercised or settled in accordance with their terms. An Award can only be exercised (to the extent it is not settled automatically) by or on behalf of the Participant holding such Award.

 

8.3                              An Award can only be exercised through the use of an electronic system or platform to be designated by the Committee (if and when such system or platform has been set up by the Company), or otherwise by delivering written notice to the Company in a form approved by the Committee.

 

8.4                              Subject to Article 9.1, the Committee shall determine the Exercise Price, provided that the

 

11


 

Exercise Price for an Award which can be exercised or settled in the form of Plan Shares shall not be less than the aggregate nominal value of such Plan Shares.

 

8.5                              Upon the exercise of an Award, the applicable Exercise Price must immediately be paid in cash, wire transfer of immediately available funds or by check payable to the order of the Company, provided that the Committee, subject to applicable law, may allow that such Exercise Price is satisfied on a cashless basis as follows:

 

a.                                     by means of an immediate sale of Plan Shares underlying the Award concerned, with sale proceeds equal to the Exercise Price being paid to the Company on behalf of the relevant Participant and any remaining sale proceeds (less applicable costs and taxes, if any) being paid to such Participant;

 

b.                                     as a result of the relevant Participant forfeiting his entitlement to receive part of the Plan Shares underlying the Award concerned at FMV on the Exercise Date and charging the aggregate nominal value of the remaining Plan Shares underlying such Award against the Company’s reserves; and/or

 

c.                                      as a result of the relevant Participant surrendering and transferring Shares to the Company (which may include Plan Shares underlying the Award concerned) at FMV on the Exercise Date.

 

8.6                              The Company is authorized to withhold from any Award granted or any payment due or transfer made under any Award or under the Plan or from any compensation or other amount owing to a Participant the amount (in cash, Shares, other Awards, other property, net settlement or any combination thereof) of applicable withholding taxes due in respect of an Award, its exercise or settlement or any payment or transfer under such Award or under the Plan and to take such other action (including providing for elective payment of such amounts in cash or Shares by the Participant) as may be necessary in the option of the Company to satisfy all obligations for the payment of such taxes

 

8.7                              When an Award is exercised or settled in the form of Plan Shares, the Company may, at the discretion of the Committee, subject to applicable law and the Company’s insider trading policy:

 

a.                                     issue new Plan Shares to the relevant Participant; or

 

b.                                     transfer existing Plan Shares held by the Company to the relevant Participant,

 

provided, in each case, that Plan Shares may be delivered in the form of book-entry securities representing those Plan Shares (or beneficial ownership of those Plan Shares entitling the holder to exercise or direct the exercise of voting rights attached thereto) credited to the securities account designated by the relevant Participant. Furthermore, Plan Shares may be delivered as described in the previous sentence to a Person designated by the relevant Participant, with the prior approval of the Committee, as beneficiary of his Award.

 

8.8                              If an Award is exercised or settled in the form of Plan Shares and such Award does not relate to a whole number of Plan Shares, the number of Plan Shares underlying such

 

12


 

Award shall be rounded down to the nearest integer.

 

PRICING RESTRICTIONS FOR OPTIONS AND SARS

 

Article 9

 

9.1                              Except for Replacement Awards, the Exercise Price for an Option or SAR shall not be less than the higher of:

 

a.                                     the FMV of a Plan Share on the applicable Grant Date and, in case of a SAR being granted in connection with an Option, on the Grant Date of such Option; or

 

b.                                     the nominal value of a Plan Share.

 

9.2                              Except as provided in Article 4.10, the Committee may not, without prior approval of the General Meeting, seek to effect any re-pricing of any outstanding “underwater” Option or SAR by:

 

a.                                     amending or modifying the terms of such Award to lower the Exercise Price;

 

b.                                     cancelling such Award and granting in exchange either (i) replacement Options or SARs having a lower Exercise Price, or (ii) Restricted Stock, RSUs or Other Awards; or

 

c.                                      cancelling or repurchasing such Award for cash, assets or other securities.

 

9.3                              Options and SARs will be considered to be “underwater” within the meaning of Article 9.1 at any time when the FMV of the Plan Shares underlying such Awards is less than the applicable Exercise Price.

 

U.S. PARTICIPANTS

 

Article 10

 

10.1                       With respect to any Award subject to Section 409A IRC, this Plan and the applicable Award Agreement are intended to comply with the requirements of Section 409A IRC, the provisions of this Plan and such Award Agreement shall be interpreted in a manner that satisfies the requirements of Section 409A IRC, and this Plan shall be operated accordingly. If any provision of this Plan or any term or condition of any Award subject to Section 409A IRC would otherwise frustrate or conflict with this intent, the provision, term or condition will be interpreted and deemed amended so as to avoid this conflict.

 

10.2                       If all or part of any payments made, or other benefits conferred, under any Award subject to Section 409A IRC constitutes deferred compensation for purposes of Section 409A IRC as a result of a “separation from service” of the relevant Participant (other than due to his death) within the meaning of Section 409A IRC while such Participant is a “specified employee” under Section 409A IRC, then such payment or benefit shall not be made or conferred until six months and one business day have elapsed after the date of such

 

13


 

“separation from service”, except as permitted under Section 409A IRC.

 

10.3                       If an Award subject to Section 409A IRC includes a “series of installment payments” within the meaning of Section 1.409A-2(b)(2)(iii) of the United States Treasury Regulations, the right of the relevant Participant to such series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment, and if such an Award includes “dividend equivalents” within the meaning of Section 1.409A-3(e) of the United States Treasury Regulations, the right of the relevant Participant to such dividend equivalents shall be treated separately from the right to other amounts or other benefits under such Award.

 

10.4                       For any Award subject to Section 409A IRC that provides for accelerated distribution on a Change of Control of amounts that constitute “deferred compensation” as defined in Section 409A IRC, if the event that constitutes such Change of Control does not also constitute a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the Company’s assets (in either case, as defined in Section 409A IRC), such amount shall not be distributed on such Change in Control but instead shall vest as of the date of such Change of Control and shall be paid on the scheduled payment date specified in the applicable Award Agreement, except to the extent that earlier distribution would not result in the relevant Participant incurring any additional tax, penalty, interest or other expense under Section 409A IRC.

 

10.5                       Notwithstanding the foregoing in this Article 10, the tax treatment of the benefits provided under this Plan or any Award Agreement is not warranted or guaranteed, and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by a U.S. Participant on account of non-compliance with Section 409A IRC.

 

LEAVER

 

Article 11

 

11.1                       If a Participant becomes a Good Leaver, unless otherwise determined by the Committee or set forth in an Award Agreement:

 

a.                                     all vested Awards that have not yet been exercised or settled must be exercised or settled in accordance with their terms within a period specified by the Committee and, if such Awards are not exercised or (through no fault of the Participant concerned) not settled within such period, they shall be cancelled automatically without compensation for the loss of such Awards; and

 

b.                                     all unvested Awards of such Participant shall be cancelled automatically without compensation for the loss of the such Awards, unless the Committee decides otherwise.

 

11.2                       If a Participant becomes a Bad Leaver, all vested Awards of such Participant which have

 

14


 

not been exercised or settled, as well as all unvested Awards of such Participant, shall be cancelled automatically without compensation for the loss of such Awards.

 

CHANGE OF CONTROL

 

Article 12

 

12.1                       If long-term incentive awards are granted in assumption of, or in substitution or exchange for, outstanding Awards in connection with a Change of Control and the Committee has determined that such awards are sufficiently equivalent to the outstanding Awards concerned, then such outstanding Awards shall be cancelled and terminated upon the replacement awards being granted to the Participants concerned.

 

12.2                       If, in connection with a Change of Control, outstanding Awards are not replaced by long-term incentive awards as described in Article 12.1, or are replaced by long-term incentive awards which the Committee does not consider to be sufficiently equivalent to such outstanding Awards, then such Awards shall immediately vest and, where relevant, settle in full, unless the Committee decides otherwise.

 

12.3                       For purposes of this Article 12, awards shall not be considered to be “sufficiently equivalent” to outstanding Awards, if the underlying securities are not widely held and publicly traded on a regulated national stock exchange.

 

LOCK-UP

 

Article 13

 

In connection with any registration of the Company’s securities, to the extent requested by the Company or the underwriters managing any public offering of the Company’s securities, and except (a) as otherwise approved by the Committee, or (b) pursuant to any exceptions approved by the underwriters, Shares acquired by a Participant pursuant to the issuance, vesting, exercise, or settlement of any Award granted hereunder may not be sold, transferred, or otherwise disposed of prior to such period following the effective date of such registration as designated by the underwriters, not to exceed 180 days following such registration (the “Lock-Up Period”). The Company may impose stop-transfer instructions with respect to the Shares subject to the foregoing restriction until the end of such Lock-Up Period.

 

DATA PROTECTION

 

Article 14

 

14.1                       The Company may process personal data relating to the Participants in connection with the administration and operation of this Plan. The personal data of the Participants which may be processed in this respect may include a copy of an identification document, contact details and bank and securities account numbers. Each Participant’s personal data shall

 

15


 

be stored by the Company for such time period as is necessary to administer such Participant’s participation in the Plan or as otherwise permitted under applicable law.

 

14.2                       Each Participant’s personal data shall be handled by the Company in a proper and careful manner in accordance with applicable law, including the General Data Protection Regulation (GDPR) and the rules and regulations promulgated pursuant thereto. Participants have the right to lodge complaints with an applicable supervisory authority regarding the Company’s processing of personal data pursuant to this Plan.

 

14.3                       The Company shall implement technical and organisational measures designed to protect personal data processed pursuant to Article 13.1. Personnel or third parties that have access to such personal data shall be bound by confidentiality obligations.

 

14.4                       The Company shall abide by any statutory rights the Participants may have regarding their respective personal data processed pursuant to Article 13.1, which includes the right to access, rectification, erasure, restriction of processing, objection to processing and portability of such personal data.

 

14.5                       In connection with the administration and operation of this Plan, the Company may transfer personal data processed pursuant to Article 13.1 to one or more third parties, provided that there is a legitimate interest in doing so. Where such third parties are located outside the European Economic Area in countries that are not considered to provide for an adequate level of data protection, the Company shall ensure that sufficient data protection safeguards are put in place, failing which explicit consent for such transfer shall be obtained from the Participant(s) concerned.

 

14.7                       The Company may establish one or more privacy policies providing further information on data protection and applying to the processing of personal data of the Participants by the Company in connection with the administration and operation of this Plan.

 

AMENDMENT AND TERMINATION

 

Article 15

 

Pursuant to a resolution to that effect, the Supervisory Board may amend, supplement or terminate this Plan, provided that no such amendment, supplement or termination shall take effect without:

 

a.                                     approval of the General Meeting, if such approval is required by applicable law or stock exchange rules; and/or

 

b.                                     the consent of the affected Participant(s), if such action would materially and adversely affect the rights of such Participant(s) under any outstanding Award, except to the extent that any such amendment, supplement or termination is made to cause this Plan to comply with applicable law, stock exchange rules, accounting principles or tax rules and regulations.

 

16


 

GOVERNING LAW AND JURISDICTION

 

Article 16

 

This Plan shall be governed by and shall be construed in accordance with the laws of the Netherlands. Subject to Article 3.1 paragraph g., any dispute arising in connection with these rules shall be submitted to the exclusive jurisdiction of the competent court in Amsterdam, the Netherlands.

 

17